Literature DB >> 1320948

Reduced activity of Na(+)-K+ ATPase of pancreatic islets in chronic renal failure: role of secondary hyperparathyroidism.

S M Hajjar1, G Z Fadda, P Thanakitcharu, M Smogorzewski, S G Massry.   

Abstract

The activity of Na(+)-K+ ATPase of pancreatic islets modulates their insulin secretion. The study presented here examined the activity of this enzyme in pancreatic islets of chronic renal failure (CRF) rats in an effort to further delineate the mechanisms of impaired insulin secretion in CRF. The Vmax of Na(+)-K+ ATPase, but not its Km, and the ATP content are significantly reduced in islets of CRF rats that have elevated levels of parathyroid hormone (PTH). These derangements are prevented by prior parathyroidectomy of CRF rats (low blood levels of PTH) or by their treatment with the calcium channel blocker verapamil; these latter rats have sustained elevation of blood levels of PTH. The data indicate that the chronic excess blood levels of PTH in CRF initiates events (augmented entry of calcium) that lead to the reduction in ATP content and in Vmax of Na(+)-K+ ATPase of pancreatic islets. Reducing the blood levels of PTH by parathyroidectomy or blocking the action of PTH on calcium entry into cells by verapamil prevents these derangements. The results suggest that chronic inhibition of Na(+)-K+ ATPase may participate in the processes underlying the impaired insulin secretion in CRF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320948     DOI: 10.1681/ASN.V281355

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  1 in total

1.  Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

Authors:  Laetitia Koppe; Elsa Nyam; Kevin Vivot; Jocelyn E Manning Fox; Xiao-Qing Dai; Bich N Nguyen; Dominique Trudel; Camille Attané; Valentine S Moullé; Patrick E MacDonald; Julien Ghislain; Vincent Poitout
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.